Ark Invest co-founder and CEO Cathie Wood is one of the best-known growth investors in the realm of exchange-traded funds ...

A steep sell-off in Roblox (RBLX) stock saw ARK Investment add to its position in the company, shrugging off fears about its user metrics and ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

EST Cathie Wood’s ARK Investment buys 250K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

In January, Tesla's new car registrations in Germany plunged 59.5% to 1,277, despite hosting its sole European factory. Sales ...

Palantir (NASDAQ:PLTR) stock has been the talk of the town again after shares skyrocketed more than 22% following an ...

In this article, we will take a look at 15 stocks in Cathie Wood’s stock portfolio. Cathie Wood is one of Wall Street’s most ...

Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

Feb. 4, 2025, Cathie Wood-led Ark Invest dumped $7.4 million worth of Palantir stock even as the shares rose 24% over ...